Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?

Detalhes bibliográficos
Autor(a) principal: Melo, Daniela Oliveira de
Data de Publicação: 2016
Outros Autores: Storpirtis, Sílvia, Ribeiro, Eliane
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/128335
Resumo: The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex(r) DrugReax(r) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; p
id USP-31_c8dbca404c97e14c5f35ce625a5ca193
oai_identifier_str oai:revistas.usp.br:article/128335
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients? The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex(r) DrugReax(r) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; pUniversidade de São Paulo. Faculdade de Ciências Farmacêuticas2016-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/12833510.1590/s1984-82502016000300005Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 3 (2016); 391-401Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 3 (2016); 391-401Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 3 (2016); 391-4012175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/128335/125207Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessMelo, Daniela Oliveira deStorpirtis, SílviaRibeiro, Eliane2017-03-16T17:54:50Zoai:revistas.usp.br:article/128335Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-03-16T17:54:50Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
spellingShingle Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
Melo, Daniela Oliveira de
title_short Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_full Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_fullStr Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_full_unstemmed Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
title_sort Does hospital admission provide an opportunity for improving pharmacotherapy among elderly inpatients?
author Melo, Daniela Oliveira de
author_facet Melo, Daniela Oliveira de
Storpirtis, Sílvia
Ribeiro, Eliane
author_role author
author2 Storpirtis, Sílvia
Ribeiro, Eliane
author2_role author
author
dc.contributor.author.fl_str_mv Melo, Daniela Oliveira de
Storpirtis, Sílvia
Ribeiro, Eliane
description The purpose of the work was to assess the incidence of potential drug interactions (pDDI), major pDDI, and the use of potentially inappropriate medication (PIM) at hospital admission, during hospitalization, and at discharge to evaluate whether hospital admission provides an opportunity for improving pharmacotherapy in elderly patients at a University hospital that has a clinical pharmacist. A prospective cohort study was carried out using data from the medical records of patients admitted to an internal medicine ward. All admissions and prescriptions were monitored between March and August 2006. Micromedex(r) DrugReax(r) and Beers Criteria 2015 were used to identify pDDI, major pDDI, and PIMs, respectively. A comparison of admission and discharge prescriptions showed the following: an increase in the proportion of patients using antithrombotic agents (76 versus 144; p
publishDate 2016
dc.date.none.fl_str_mv 2016-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/128335
10.1590/s1984-82502016000300005
url https://www.revistas.usp.br/bjps/article/view/128335
identifier_str_mv 10.1590/s1984-82502016000300005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/128335/125207
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 52 Núm. 3 (2016); 391-401
Brazilian Journal of Pharmaceutical Sciences; v. 52 n. 3 (2016); 391-401
Brazilian Journal of Pharmaceutical Sciences; Vol. 52 No. 3 (2016); 391-401
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222912821592064